Literature DB >> 20219929

Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus.

Sanjay Chandriani1, Don Ganem.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is a B-lymphotropic herpesvirus strongly linked to both lymphoproliferative diseases and Kaposi's sarcoma. The viral latency program of KSHV is central to persistent infection and plays important roles in the pathogenesis of KSHV-related tumors. Up to six polypeptides and 18 microRNAs are known to be expressed in latency, but it is unclear if all major latency genes have been identified. Here, we have employed array-based transcript profiling and limiting-dilution reverse transcription-PCR (RT-PCR) methodologies to explore this issue in several KSHV-infected cell lines. Our results show that RNAs encoding the K1 protein are found at low levels in most latently infected cell lines. The gene encoding v-IL-6 is also expressed as a latent transcript in some contexts. Both genes encode powerful signaling molecules with particular relevance to B cell biology: K1 mimics signaling through the B cell receptor, and v-IL-6 promotes B cell survival. These data resolve earlier controversies about K1 and v-IL-6 expression and indicate that, in addition to core latency genes, some transcripts can be expressed in KSHV latency in a context-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219929      PMCID: PMC2876603          DOI: 10.1128/JVI.02723-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Sadler; L Wu; B Forghani; R Renne; W Zhong; B Herndier; D Ganem
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein.

Authors:  O Brad Spiller; Mairi Robinson; Elizabeth O'Donnell; Steven Milligan; B Paul Morgan; Andrew J Davison; David J Blackbourn
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus.

Authors:  Brian S Bowser; Scott M DeWire; Blossom Damania
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays.

Authors:  Dirk P Dittmer
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

5.  Viral IL-6-induced cell proliferation and immune evasion of interferon activity.

Authors:  Malini Chatterjee; Julie Osborne; Giovanna Bestetti; Yuan Chang; Patrick S Moore
Journal:  Science       Date:  2002-11-15       Impact factor: 47.728

Review 6.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

Review 7.  The molecular pathology of Kaposi's sarcoma-associated herpesvirus.

Authors:  Richard G Jenner; Chris Boshoff
Journal:  Biochim Biophys Acta       Date:  2002-03-14

8.  A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Masahiro Fujimuro; Frederick Y Wu; Colette ApRhys; Henry Kajumbula; David B Young; Gary S Hayward; S Diane Hayward
Journal:  Nat Med       Date:  2003-02-18       Impact factor: 53.440

9.  KSHV vFLIP binds to IKK-gamma to activate IKK.

Authors:  Nigel Field; Walter Low; Mark Daniels; Steven Howell; Laurent Daviet; Chris Boshoff; Mary Collins
Journal:  J Cell Sci       Date:  2003-07-30       Impact factor: 5.285

10.  KSHV vFLIP is essential for the survival of infected lymphoma cells.

Authors:  Ilaria Guasparri; Shannon A Keller; Ethel Cesarman
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

View more
  76 in total

1.  The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes.

Authors:  Sanjay Chandriani; Yiyang Xu; Don Ganem
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 2.  Cytokine homologs of human gammaherpesviruses.

Authors:  Sang-Hoon Sin; Dirk P Dittmer
Journal:  J Interferon Cytokine Res       Date:  2011-12-05       Impact factor: 2.607

3.  Multiple defects, including premature apoptosis, prevent Kaposi's sarcoma-associated herpesvirus replication in murine cells.

Authors:  Kathryn Austgen; Scott A Oakes; Don Ganem
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

Review 4.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

5.  Latent Kaposi's sarcoma-associated herpesvirus infection of monocytes downregulates expression of adaptive immune response costimulatory receptors and proinflammatory cytokines.

Authors:  Sean M Gregory; Ling Wang; John A West; Dirk P Dittmer; Blossom Damania
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 6.  Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.

Authors:  Ethel Cesarman
Journal:  Cancer Lett       Date:  2011-04-13       Impact factor: 8.679

Review 7.  Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.

Authors:  Emily Cousins; John Nicholas
Journal:  Recent Results Cancer Res       Date:  2014

8.  Latent KSHV infection increases the vascular permeability of human endothelial cells.

Authors:  Christophe Guilluy; Zhigang Zhang; Prasanna M Bhende; Lisa Sharek; Ling Wang; Keith Burridge; Blossom Damania
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

9.  Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.

Authors:  Jinjong Myoung; Don Ganem
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

Review 10.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.